Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap5.12B
Enterprise Value3.71B
P/E Ratio21.17
PEG Ratio0.19
Price/Sales Ratio5.65
Price/Book Ratio1.91
Enterprise/Revenue4.39
Enterprise/EBITDA13.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.27
Operating Margin0.29
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.09

Income Statement

Revenue1.05B
Revenue/Share2.7
Gross Profit653.4M
EBITDA309.43M
Net Income272.54M
Diluted EPS0.71

Balance Sheet

Total Cash2.1B
Total Cash/Share5.52
Total Debt2.23M
Total Debt/Equity0
Current Ratio6.09
Book Value Per Share7.98

Price History

52-Week Change-21.25
52-Week High20.82
52-Week Low8.48
Moving Average 50 Days10.71
Moving Average 200 Days14.12

Statistics

Average Volume969,353
Shares Outstanding595.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.26
Trailing Annual Dividend Yield1.7
Payout Ratio0.65
Last Split Factor5:2
Last Split DateApril 20, 2020
AD